TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
GHN Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,997
|
296
|
6,114 |
Financial expenses |
11
|
2,436
|
316 |
Earnings before taxes |
5,290
|
-2,975
|
15,372 |
EBITDA |
-60
|
-2,014
|
-1,548 |
Total assets |
95,545
|
90,619
|
94,545 |
Current assets |
2,969
|
2,403
|
3,386 |
Current liabilities |
846
|
210
|
341 |
Equity capital |
94,699
|
90,409
|
94,204 |
- share capital |
412
![]() |
412
![]() |
412 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
99.1%
|
99.8%
|
99.6% |
Turnover per employee |
998
|
148
|
3,057 |
Profit as a percentage of turnover |
264.9%
|
-1005.1%
|
251.4% |
Return on assets (ROA) |
5.5%
|
-0.6%
|
16.6% |
Current ratio |
350.9%
|
1144.3%
|
993.0% |
Return on equity (ROE) |
5.6%
|
-3.3%
|
16.3% |
Change turnover |
1,701
|
-5,818
|
6,033 |
Change turnover % |
575%
|
-95%
|
7448% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.